FDA warns about azithromycin in some cancers
Aug 07, 2018•8 min•Season 1Ep. 131
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
The FDA has issued a safety alert warning against long-term use of azithromycin to prevent bronchiolitis obliterans syndrome in patients with blood or lymph node cancers. Also today, four syndromes suggest life-threatening PVL-positive Staphylococcus aureus infection, asthma medication ratio identifies high-risk pediatric patients, and new MS criteria may create more false positives.
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast